Replimune (REPL) Net Income towards Common Stockholders (2017 - 2025)
Replimune has reported Net Income towards Common Stockholders over the past 9 years, most recently at -$70.9 million for Q4 2025.
- Quarterly results put Net Income towards Common Stockholders at -$70.9 million for Q4 2025, down 6.92% from a year ago — trailing twelve months through Dec 2025 was -$314.9 million (down 37.95% YoY), and the annual figure for FY2025 was -$247.3 million, down 14.6%.
- Net Income towards Common Stockholders reached -$70.9 million in Q4 2025 per REPL's latest filing, up from -$83.1 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$21.5 million in Q1 2021 and bottomed at -$86.7 million in Q2 2025.
- Median Net Income towards Common Stockholders over the past 5 years was -$50.3 million (2023), compared with a mean of -$50.9 million.
- The largest annual shift saw Net Income towards Common Stockholders increased 11.64% in 2024 before it tumbled 61.22% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$29.7 million in 2021, then plummeted by 33.75% to -$39.7 million in 2022, then dropped by 28.8% to -$51.1 million in 2023, then fell by 29.77% to -$66.3 million in 2024, then dropped by 6.92% to -$70.9 million in 2025.
- Business Quant data shows Net Income towards Common Stockholders for REPL at -$70.9 million in Q4 2025, -$83.1 million in Q3 2025, and -$86.7 million in Q2 2025.